1. Home
  2. ENZ vs RNXT Comparison

ENZ vs RNXT Comparison

Compare ENZ & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENZ
  • RNXT
  • Stock Information
  • Founded
  • ENZ 1976
  • RNXT 2012
  • Country
  • ENZ United States
  • RNXT United States
  • Employees
  • ENZ N/A
  • RNXT N/A
  • Industry
  • ENZ Medical Specialities
  • RNXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENZ Health Care
  • RNXT Health Care
  • Exchange
  • ENZ Nasdaq
  • RNXT Nasdaq
  • Market Cap
  • ENZ 34.2M
  • RNXT 31.6M
  • IPO Year
  • ENZ N/A
  • RNXT 2021
  • Fundamental
  • Price
  • ENZ $0.52
  • RNXT $1.12
  • Analyst Decision
  • ENZ
  • RNXT Strong Buy
  • Analyst Count
  • ENZ 0
  • RNXT 1
  • Target Price
  • ENZ N/A
  • RNXT $9.00
  • AVG Volume (30 Days)
  • ENZ 125.3K
  • RNXT 202.5K
  • Earning Date
  • ENZ 03-12-2025
  • RNXT 03-31-2025
  • Dividend Yield
  • ENZ N/A
  • RNXT N/A
  • EPS Growth
  • ENZ N/A
  • RNXT N/A
  • EPS
  • ENZ N/A
  • RNXT N/A
  • Revenue
  • ENZ $30,314,000.00
  • RNXT N/A
  • Revenue This Year
  • ENZ N/A
  • RNXT N/A
  • Revenue Next Year
  • ENZ N/A
  • RNXT N/A
  • P/E Ratio
  • ENZ N/A
  • RNXT N/A
  • Revenue Growth
  • ENZ N/A
  • RNXT N/A
  • 52 Week Low
  • ENZ $0.51
  • RNXT $0.77
  • 52 Week High
  • ENZ $1.40
  • RNXT $1.86
  • Technical
  • Relative Strength Index (RSI)
  • ENZ 22.58
  • RNXT 36.31
  • Support Level
  • ENZ $0.56
  • RNXT $1.09
  • Resistance Level
  • ENZ $0.69
  • RNXT $1.40
  • Average True Range (ATR)
  • ENZ 0.03
  • RNXT 0.10
  • MACD
  • ENZ -0.00
  • RNXT -0.03
  • Stochastic Oscillator
  • ENZ 8.13
  • RNXT 8.51

About ENZ Enzo Biochem Inc. ($0.01 Par Value)

Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: